-
1
-
-
84875722622
-
Molecular aspects of cancer cell resistance to chemotherapy
-
Rebucci M, Michiels C. Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol 2013; 85: 1219-26.
-
(2013)
Biochem Pharmacol
, vol.85
, pp. 1219-1226
-
-
Rebucci, M.1
Michiels, C.2
-
3
-
-
29344443251
-
The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors
-
Primeau AJ, Rendon A, Hedley D, Lilge L, Tannock IF. The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors. Clin Cancer Res 2005; 11: 8782-8.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 8782-8788
-
-
Primeau, A.J.1
Rendon, A.2
Hedley, D.3
Lilge, L.4
Tannock, I.F.5
-
4
-
-
84879795835
-
Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues
-
Patel KJ, Tredan O, Tannock IF. Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues. Cancer Chemother Pharmacol 2013; 72: 127-38.
-
(2013)
Cancer Chemother Pharmacol
, vol.72
, pp. 127-138
-
-
Patel, K.J.1
Tredan, O.2
Tannock, I.F.3
-
5
-
-
84876471485
-
Use of molecular biomarkers to quantify the spatial distribution of effects of anticancer drugs in solid tumors
-
Saggar JK, Fung AS, Patel KJ, Tannock IF. Use of molecular biomarkers to quantify the spatial distribution of effects of anticancer drugs in solid tumors. Mol Cancer Ther 2013a; 12: 542-52.
-
(2013)
Mol Cancer Ther
, vol.12
, pp. 542-552
-
-
Saggar, J.K.1
Fung, A.S.2
Patel, K.J.3
Tannock, I.F.4
-
7
-
-
84891053440
-
The tumor microenvironment and strategies to improve drug distribution
-
Saggar JK, Yu M, Tan Q, Tannock IF. The tumor microenvironment and strategies to improve drug distribution. Front Oncol 2013; 3: 154.
-
(2013)
Front Oncol
, vol.3
, pp. 154
-
-
Saggar, J.K.1
Yu, M.2
Tan, Q.3
Tannock, I.F.4
-
8
-
-
84938598513
-
Chemotherapy rescues hypoxic tumor cells and induces their reoxygenation and repopulation - an effect that is inhibited by the hypoxia-activated pro-drug TH-302
-
Saggar JK, Tannock IF. Chemotherapy rescues hypoxic tumor cells and induces their reoxygenation and repopulation - an effect that is inhibited by the hypoxia-activated pro-drug TH-302. Clin Cancer Res 2015; 21: 2107-14.
-
(2015)
Clin Cancer Res
, vol.21
, pp. 2107-2114
-
-
Saggar, J.K.1
Tannock, I.F.2
-
9
-
-
34447258681
-
Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize
-
Fukumura D, Jain RK. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem 2007; 101: 937-49.
-
(2007)
J Cell Biochem
, vol.101
, pp. 937-949
-
-
Fukumura, D.1
Jain, R.K.2
-
10
-
-
72149101372
-
The pK(a) distribution of drugs: application to drug discovery
-
Manallack DT. The pK(a) distribution of drugs: application to drug discovery. Perspect Medicin Chem 2007; 1: 25-38.
-
(2007)
Perspect Medicin Chem
, vol.1
, pp. 25-38
-
-
Manallack, D.T.1
-
11
-
-
0034104453
-
Resistance mechanisms associated with altered intracellular distribution of anticancer agents
-
Larsen AK, Escargueil AE, Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000; 85: 217-29.
-
(2000)
Pharmacol Ther
, vol.85
, pp. 217-229
-
-
Larsen, A.K.1
Escargueil, A.E.2
Skladanowski, A.3
-
12
-
-
36349001899
-
Targeting vacuolar H+-ATPases as a new strategy against cancer
-
Fais S, De Milito A, You H, Qin W. Targeting vacuolar H+-ATPases as a new strategy against cancer. Cancer Res 2007; 67: 10627-30.
-
(2007)
Cancer Res
, vol.67
, pp. 10627-10630
-
-
Fais, S.1
De Milito, A.2
You, H.3
Qin, W.4
-
13
-
-
84919390069
-
V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells
-
Schempp CM, von Schwarzenberg K, Schreiner L et al. V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells. Mol Cancer Ther 2014; 13: 926-37.
-
(2014)
Mol Cancer Ther
, vol.13
, pp. 926-937
-
-
Schempp, C.M.1
von Schwarzenberg, K.2
Schreiner, L.3
-
15
-
-
0028282608
-
H(+)-ATPases of renal cortical and medullary endosomes are differentially sensitive to Sch-28080 and omeprazole
-
Sabolic I, Brown D, Verbavatz JM, Kleinman J. H(+)-ATPases of renal cortical and medullary endosomes are differentially sensitive to Sch-28080 and omeprazole. Am J Physiol 1994; 266(6 Pt 2): F868-77.
-
(1994)
Am J Physiol
, vol.266
, Issue.6
, pp. F868-F877
-
-
Sabolic, I.1
Brown, D.2
Verbavatz, J.M.3
Kleinman, J.4
-
16
-
-
84857749232
-
A rationale for the use of proton pump inhibitors as antineoplastic agents
-
De Milito A, Marino ML, Fais S. A rationale for the use of proton pump inhibitors as antineoplastic agents. Curr Pharm Des 2012; 18: 1395-406.
-
(2012)
Curr Pharm Des
, vol.18
, pp. 1395-1406
-
-
De Milito, A.1
Marino, M.L.2
Fais, S.3
-
18
-
-
84928700976
-
Effects of pantoprazole to enhance activity of docetaxel against human tumor xenografts by inhibiting autophagy
-
Tan Q, Joshua A, Saggar J et al. Effects of pantoprazole to enhance activity of docetaxel against human tumor xenografts by inhibiting autophagy. Br J Cancer, 2015; 112: 832-40.
-
(2015)
Br J Cancer
, vol.112
, pp. 832-840
-
-
Tan, Q.1
Joshua, A.2
Saggar, J.3
-
19
-
-
84904048411
-
Autophagy inhibition improves chemosensitivity in BRAFV600E brain tumors
-
Levy JM, Thompson JC, Griesinger AM et al. Autophagy inhibition improves chemosensitivity in BRAFV600E brain tumors. Cancer Discov 2014; 4: 773-80.
-
(2014)
Cancer Discov
, vol.4
, pp. 773-780
-
-
Levy, J.M.1
Thompson, J.C.2
Griesinger, A.M.3
-
20
-
-
84902494027
-
Role of autophagy in cisplatin resistance in ovarian cancer cells
-
Wang J, Wu GS. Role of autophagy in cisplatin resistance in ovarian cancer cells. J Biol Chem 2014; 289: 17163-73.
-
(2014)
J Biol Chem
, vol.289
, pp. 17163-17173
-
-
Wang, J.1
Wu, G.S.2
-
21
-
-
84901356565
-
S100A8 contributes to drug resistance by promoting autophagy in leukemia cells
-
Yang M, Zeng P, Kang R et al. S100A8 contributes to drug resistance by promoting autophagy in leukemia cells. PLoS ONE 2014; 9: e97242.
-
(2014)
PLoS ONE
, vol.9
, pp. e97242
-
-
Yang, M.1
Zeng, P.2
Kang, R.3
-
22
-
-
84890662504
-
Use of the proton pump inhibitor pantoprazole to modify the distribution and activity of doxorubicin: a potential strategy to improve the therapy of solid tumors
-
Patel KJ, Lee C, Tan Q, Tannock IF. Use of the proton pump inhibitor pantoprazole to modify the distribution and activity of doxorubicin: a potential strategy to improve the therapy of solid tumors. Clin Cancer Res 2013; 19: 6766-76.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 6766-6776
-
-
Patel, K.J.1
Lee, C.2
Tan, Q.3
Tannock, I.F.4
-
23
-
-
33645307960
-
Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration
-
Lee CM, Tannock IF. Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration. Br J Cancer 2006; 94: 863-9.
-
(2006)
Br J Cancer
, vol.94
, pp. 863-869
-
-
Lee, C.M.1
Tannock, I.F.2
-
24
-
-
9744260934
-
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs
-
Luciani F, Spada M, De Milito A et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 2004; 96: 1702-13.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 1702-1713
-
-
Luciani, F.1
Spada, M.2
De Milito, A.3
-
25
-
-
84886035271
-
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed
-
Ferrari S, Perut F, Fagioli F et al. Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed. J Transl Med 2013; 11: 268.
-
(2013)
J Transl Med
, vol.11
, pp. 268
-
-
Ferrari, S.1
Perut, F.2
Fagioli, F.3
-
26
-
-
0032978250
-
Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors
-
Tunggal JK, Cowan DS, Shaikh H, Tannock IF. Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors. Clin Cancer Res 1999; 5: 1583-6.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 1583-1586
-
-
Tunggal, J.K.1
Cowan, D.S.2
Shaikh, H.3
Tannock, I.F.4
-
27
-
-
0040298568
-
Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
-
Janicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998; 273: 9357-60.
-
(1998)
J Biol Chem
, vol.273
, pp. 9357-9360
-
-
Janicke, R.U.1
Sprengart, M.L.2
Wati, M.R.3
Porter, A.G.4
-
28
-
-
84860612152
-
Quantitative immunohistochemistry for evaluating the distribution of Ki67 and other biomarkers in tumor sections and use of the method to study repopulation in xenografts after treatment with paclitaxel
-
Fung AS, Jonkman J, Tannock IF. Quantitative immunohistochemistry for evaluating the distribution of Ki67 and other biomarkers in tumor sections and use of the method to study repopulation in xenografts after treatment with paclitaxel. Neoplasia 2012; 14: 324-34.
-
(2012)
Neoplasia
, vol.14
, pp. 324-334
-
-
Fung, A.S.1
Jonkman, J.2
Tannock, I.F.3
-
29
-
-
0036307898
-
Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy
-
Tannock IF, Lee CM, Tunggal JK, Cowan DS, Egorin MJ. Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 2002; 8: 878-84.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 878-884
-
-
Tannock, I.F.1
Lee, C.M.2
Tunggal, J.K.3
Cowan, D.S.4
Egorin, M.J.5
-
30
-
-
84914105725
-
Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy
-
Fais S, Venturi G, Gatenby B. Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy. Cancer Metastasis Rev 2014; 33: 1095-108.
-
(2014)
Cancer Metastasis Rev
, vol.33
, pp. 1095-1108
-
-
Fais, S.1
Venturi, G.2
Gatenby, B.3
-
31
-
-
71749102668
-
Microenvironmental pH is a key factor for exosome traffic in tumor cells
-
Parolini I, Federici C, Raggi C et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009; 284: 34211-22.
-
(2009)
J Biol Chem
, vol.284
, pp. 34211-34222
-
-
Parolini, I.1
Federici, C.2
Raggi, C.3
-
32
-
-
84895552868
-
Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin
-
Federici C, Petrucci F, Caimi S et al. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS ONE 2014; 9: e88193.
-
(2014)
PLoS ONE
, vol.9
, pp. e88193
-
-
Federici, C.1
Petrucci, F.2
Caimi, S.3
-
33
-
-
84904685127
-
Autophagy: detection, regulation and its role in cancer and therapy response
-
Honscheid P, Datta K, Muders MH. Autophagy: detection, regulation and its role in cancer and therapy response. Int J Radiat Biol 2014; 90: 628-35.
-
(2014)
Int J Radiat Biol
, vol.90
, pp. 628-635
-
-
Honscheid, P.1
Datta, K.2
Muders, M.H.3
-
34
-
-
84865800743
-
Autophagy is a protective mechanism for human melanoma cells under acidic stress
-
Marino ML, Pellegrini P, Di Lernia G et al. Autophagy is a protective mechanism for human melanoma cells under acidic stress. J Biol Chem 2012; 287: 30664-76.
-
(2012)
J Biol Chem
, vol.287
, pp. 30664-30676
-
-
Marino, M.L.1
Pellegrini, P.2
Di Lernia, G.3
-
35
-
-
77950501364
-
Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism
-
Fais S. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism. J Intern Med 2010; 267: 515-25.
-
(2010)
J Intern Med
, vol.267
, pp. 515-525
-
-
Fais, S.1
-
36
-
-
84919430919
-
Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma
-
Azzarito T, Venturi G, Cesolini A, Fais S. Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma. Cancer Lett 2015; 356(2 Pt B): 697-703.
-
(2015)
Cancer Lett
, vol.356
, Issue.2
, pp. 697-703
-
-
Azzarito, T.1
Venturi, G.2
Cesolini, A.3
Fais, S.4
-
37
-
-
34347207246
-
Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species
-
De Milito A, Iessi E, Logozzi M et al. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res 2007; 67: 5408-17.
-
(2007)
Cancer Res
, vol.67
, pp. 5408-5417
-
-
De Milito, A.1
Iessi, E.2
Logozzi, M.3
-
38
-
-
77953463274
-
pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity
-
De Milito A, Canese R, Marino ML et al. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer 2010; 127: 207-19.
-
(2010)
Int J Cancer
, vol.127
, pp. 207-219
-
-
De Milito, A.1
Canese, R.2
Marino, M.L.3
-
39
-
-
84919494190
-
Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition
-
356
-
Zhang B, Yang Y, Shi X et al. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition. Cancer Lett 356; 2(2 Pt B): 704-12.
-
Cancer Lett
, vol.2
, Issue.2
, pp. 704-712
-
-
Zhang, B.1
Yang, Y.2
Shi, X.3
-
40
-
-
84901845630
-
Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion
-
Zhang S, Wang Y, Li SJ. Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion. Biochem Biophys Res Commun 2014; 448: 424-9.
-
(2014)
Biochem Biophys Res Commun
, vol.448
, pp. 424-429
-
-
Zhang, S.1
Wang, Y.2
Li, S.J.3
-
41
-
-
84455173776
-
Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors
-
Spugnini EP, Baldi A, Buglioni S et al. Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors. J Transl Med 2011; 9: 221.
-
(2011)
J Transl Med
, vol.9
, pp. 221
-
-
Spugnini, E.P.1
Baldi, A.2
Buglioni, S.3
-
42
-
-
84908135921
-
High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors
-
Spugnini EP, Buglioni S, Carocci F et al. High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors. J Transl Med 2014; 12: 225.
-
(2014)
J Transl Med
, vol.12
, pp. 225
-
-
Spugnini, E.P.1
Buglioni, S.2
Carocci, F.3
-
43
-
-
84964314701
-
Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma
-
Papagerakis S, Bellile E, Peterson LA et al. Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma. Cancer Prev Res (Phila) 2014; 7: 1258-69.
-
(2014)
Cancer Prev Res (Phila)
, vol.7
, pp. 1258-1269
-
-
Papagerakis, S.1
Bellile, E.2
Peterson, L.A.3
-
44
-
-
84861090758
-
Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo
-
Chen M, Huang SL, Zhang XQ et al. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo. J Cell Biochem 2012; 113: 2474-87.
-
(2012)
J Cell Biochem
, vol.113
, pp. 2474-2487
-
-
Chen, M.1
Huang, S.L.2
Zhang, X.Q.3
-
45
-
-
79956342935
-
Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells
-
Udelnow A, Kreyes A, Ellinger S et al. Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. PLoS ONE 2011; 6: e20143.
-
(2011)
PLoS ONE
, vol.6
, pp. e20143
-
-
Udelnow, A.1
Kreyes, A.2
Ellinger, S.3
-
46
-
-
79958759965
-
Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells
-
Marino ML, Fais S, Djavaheri-Mergny M et al. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis 2010; 1: e87.
-
(2010)
Cell Death Dis
, vol.1
, pp. e87
-
-
Marino, M.L.1
Fais, S.2
Djavaheri-Mergny, M.3
-
47
-
-
53249121028
-
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
-
Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol 2008; 64: 935-51.
-
(2008)
Eur J Clin Pharmacol
, vol.64
, pp. 935-951
-
-
Shi, S.1
Klotz, U.2
-
48
-
-
84876811076
-
Pharmacokinetics and pharmacodynamics of the proton pump inhibitors
-
Shin JM, Kim N. Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. J Neurogastroenterol Motil 2013; 19: 25-35.
-
(2013)
J Neurogastroenterol Motil
, vol.19
, pp. 25-35
-
-
Shin, J.M.1
Kim, N.2
-
49
-
-
84858602107
-
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma
-
Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 2012; 21: 418-29.
-
(2012)
Cancer Cell
, vol.21
, pp. 418-429
-
-
Provenzano, P.P.1
Cuevas, C.2
Chang, A.E.3
Goel, V.K.4
Von Hoff, D.D.5
Hingorani, S.R.6
-
50
-
-
84927512782
-
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin
-
Brana I, Ocana A, Chen EX et al. A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin. Invest New Drugs 2014; 32: 1269-77.
-
(2014)
Invest New Drugs
, vol.32
, pp. 1269-1277
-
-
Brana, I.1
Ocana, A.2
Chen, E.X.3
|